Core Viewpoint - A securities class action lawsuit has been filed against Ardent Health, Inc. for failing to disclose material information during the class period, leading to significant financial losses for investors [3]. Group 1: Lawsuit Details - Investors who suffered substantial losses from purchasing Ardent's securities between July 18, 2024, and November 12, 2025, have until March 9, 2026, to file lead plaintiff applications [1]. - The lawsuit is pending in the United States District Court for the Middle District of Tennessee [1]. Group 2: Financial Impact - On November 12, 2025, Ardent disclosed a $43 million decrease in third quarter 2025 revenue due to revised determinations of accounts receivable collectability and recent evaluations of historical collection trends [4]. - The company cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $625 million to $530 million - $555 million, citing persistent industry-wide cost pressures [4]. - Ardent also recorded a $54 million increase in professional liability reserves related to recent settlements and ongoing litigation [4]. - Following this news, Ardent's share price fell by $4.75, or nearly 34%, from $14.05 to $9.30 per share on November 13, 2025, with unusually heavy trading volume [4]. Group 3: Legal Representation - Kahn Swick & Foti, LLC, a prominent securities litigation law firm, is representing the investors in this case [5]. - The firm has been recognized among the top 10 firms nationally based on total settlement value and serves a variety of clients seeking recoveries for investment losses due to corporate fraud [5].
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC